Literature DB >> 13627769

Clinical observations with 1, 6-bis(beta-chloroethylamino)-1, 6-deoxy-D-mannitol dihydrochloride (BCM) in malignant diseases.

C SELLEI, S ECKHARDT.   

Abstract

Entities:  

Keywords:  MANNITOL/related compounds; NITROGEN MUSTARDS/therapeutic use

Mesh:

Substances:

Year:  1958        PMID: 13627769     DOI: 10.1111/j.1749-6632.1958.tb42678.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.

Authors:  A M BARLOW; J T LEEMING; J F WILKINSON
Journal:  Br Med J       Date:  1959-08-22

2.  Chemotherapy of cancer.

Authors:  K A NEWTON
Journal:  Postgrad Med J       Date:  1958-12       Impact factor: 2.401

3.  Nitrogen mustard in palliation of mslignant effusions.

Authors:  V B LEVISON
Journal:  Br Med J       Date:  1961-04-22

4.  The Clinical Application of Bone Marrow Grafting.

Authors:  D E Pegg; J G Humble; K A Newton
Journal:  Br J Cancer       Date:  1962-09       Impact factor: 7.640

5.  Tumour-inhibiting action of 1,6-di-(2-bromoethyl-amino)-1,6-dideoxy-D-mannitol dihydrobromide [(DBM (R13)].

Authors:  J BALO; G KENDREY; J JUHASZ; I BESZNYAK
Journal:  Br J Cancer       Date:  1959-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.